ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Share Price Pass Below 50-Day Moving Average – What’s Next?

Posted by Paula Ricardo on May 2nd, 2026

Shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $8.82 and traded as low as $8.71. ProShares UltraShort Nasdaq Biotechnology shares last traded at $8.72, with a volume of 16,237 shares.

ProShares UltraShort Nasdaq Biotechnology Price Performance

The firm has a 50-day moving average price of $8.82 and a two-hundred day moving average price of $9.42.

Hedge Funds Weigh In On ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Csenge Advisory Group acquired a new position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 12,421 shares of the company’s stock, valued at approximately $163,000. Csenge Advisory Group owned approximately 6.54% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the Securities & Exchange Commission.

ProShares UltraShort Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.